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Given the association between mutational load and
cancer, the observation that genetic aberrations are
frequently found in human pluripotent stem cells
(hPSCs) is of concern. Prior studies in human
induced pluripotent stem cells (hiPSCs) have shown
that deletions and regions of loss of heterozygosity
(LOH) tend to arise during reprogramming and early
culture, whereas duplications more frequently occur
during long-term culture. For the corresponding
experiments in human embryonic stem cells (hESCs),
we studied two sets of hESC lines: one including the
corresponding parental DNA and the other gener-
ated from single blastomeres from four sibling
embryos. Here, we show that genetic aberrations
observed in hESCs can originate during preimplanta-
tion embryo development and/or early derivation.
These early aberrations are mainly deletions and
LOH, whereas aberrations arising during long-term
culture of hESCs are more frequently duplications.
Our results highlight the importance of close moni-
toring of genomic integrity and the development of
improved methods for derivation and culture of
hPSCs.INTRODUCTION
Human embryonic stem cells (hESCs) are derived from the inner
cell mass (ICM) cells of blastocyst stage embryos (Itskovitz-
Eldor et al., 2000; Reubinoff et al., 2000; Thomson et al., 1998).
These cells appear to be immortal and can be maintained and
propagated in culture in an undifferentiated state essentially1288 Cell Reports 4, 1288–1302, September 26, 2013 ª2013 The Auforever, without losing their ability to proliferate. In addition,
they have the potential to develop into all three embryonic
germ layers and all of their differentiated derivatives, both in vivo
and in vitro (reviewed in Eiges and Benvenisty, 2002). In vivo,
nonmalignant tumors (teratomas) are formed when hESCs are
injected into immunodeficient mice. These tumors also demon-
strate the wide developmental potential of hESCs, with the
presence of derivatives of all embryonic germ layers. The vast
self-renewal and differentiation capacities of hESCs make
them potential sources of large quantities of differentiated cells
for drug screening and cell therapy. One of the greatest concerns
for the clinical use of hESCs or their derivatives is the element of
safety, and of all the safety issues, tumorigenicity is of the highest
priority (Ben-David and Benvenisty, 2011; Fox, 2008). As such,
extensive research into the biology of stem cells and in-depth
preclinical studies, especially those on safety, should be pur-
sued in order to maximize their potential benefits while mini-
mizing the risks of hESCs for application in regenerative
medicine.
The link between stem cells and cancer cells is supported by
increasing evidence that cancer can develop from stem cells,
and thatmany cell signaling pathways essential for normal devel-
opment are dysregulated in cancer (Catalina et al., 2009). In
addition, genetic and epigenetic instability have been strongly
associated with various types of cancer; thus, it is reasonable
to assume that evidence of such instability is undesirable in
cell preparations intended for clinical use. Catalina et al. (2009)
have shown that hESCs continue to maintain overall genetic
stability even after 70 passages (P) in culture, when grown on
human feeder cells and passaged by mechanical splitting. This
study evaluated genetic stability using G-banding karyotype
analysis, which was confirmed by fluorescence in situ hybridi-
zation, comparative genomic hybridization (CGH), and SKY ana-
lyses (a high-resolution molecular cytogenetic tool). However, it
has been shown that other culture conditions, including feeder-
free conditions and enzymatic splitting that are commonly usedthors
for the maintenance of undifferentiated hESCs, are associated
with accumulation of genetic and epigenetic alterations with
bulk passaging and extended time in culture (Baker et al.,
2007; Imreh et al., 2006; Maitra et al., 2005). These genetic
changesmay lead to quantitative differences in gene expression.
Some of the most frequent chromosomal changes observed in
hESCs, such as trisomies of chromosomes 12 and 17, are similar
to those seen in malignant germ cell tumors (Draper et al., 2004;
Mitalipova et al., 2005).
Subchromosomal abnormalities have been detected in hESCs
by CGH and SNP genotyping (Lefort et al., 2008; Na¨rva¨ et al.,
2010; Spits et al., 2008). Our lab (Laurent et al., 2011) recently
identified recurrent duplications in specific regions of the
genome in hESCs acquired with time and passaging in culture.
Similarly, other groups (Ben-David et al., 2010; Hussein et al.,
2011; Amps et al., 2011; Mayshar et al., 2010) identified several
aberrations resulting from time in culture. The most frequently
observed duplication included the region of chromosome 12
that contains pluripotency- and proliferation-associated genes,
including NANOG. These findings are a cause for concern
because overexpression of NANOG has been shown to increase
proliferation (Darr et al., 2006). These reports on instability of
hESCs and human induced pluripotent stem cells (hiPSCs)
focused on alterations detectable over the course of long-term
culture, implying that some late-passage hESC lines may be
unsuitable for therapeutic purposes. However, genetic changes
appear to be present in some hESCs even at very early pas-
sages, raising the possibility of genetic instability that occurs
already during the derivation process. These results highlight
the need to map the full range of common genetic aberrations
in hESCs, in order to define the conditions that promote/repress
genomic instability in these cells, as well as to differentiate
between aberrations that lead to phenotypic changes which
are ‘‘harmful’’ and those that are ‘‘harmless.’’ In order to develop
strategies to prevent the accumulation of genetic alterations in
hESCs, we must first identify when during the lifetime of the
cultures they are most likely to occur.
hiPSCs are easy to generate and present a good system for
determining whether a given alteration is a new event or similar
to the parental source cells that were used for their generation
(Laurent et al., 2011). However, the selective pressures imposed
by the reprogramming process itself may significantly contribute
to aneuploidy in hiPSCs (Ben-David et al., 2010; Laurent et al.,
2011). Therefore, the goal of this study was to distinguish
between the frequency and type of genetic alterations that arise
during different stages of hESC derivation and culture, specif-
ically during the period between gametogenesis and early pas-
sage of the established hESC line (including gametogenesis,
fertilization, preimplantation embryo development, derivation of
the line, and its early passage) and during long-term culture.
This information will point to key aspects of pluripotent stem
cell generation and culture that require optimization.
We took advantage of our access to two unique sets of genet-
ically related samples, together with high-resolution genomic
analysis in order to determine at a high level of precision when
a specific genetic change has occurred —during gametogen-
esis, embryogenesis, derivation, or culture. The first genetically
related samples include early and high-passage samplesCell Re(collected 30–42 passages after the early-passage samples)
from three hESC lines, which we derived (the preimplantation-
genetic-diagnosis [PGD]-derived hESC lines), and for which we
have parental DNA from the blastocyst donors. These related
samples enabled us to explore the origins of the identified
copy number variations, whether they were inherited or arose
de novo during early embryogenesis or derivation, as well as
to determine the maternal and paternal contributions to the
observed genetic changes. The three PGD-derived hESC lines
were generated from embryos that were deemed unsuitable
for reproductive purposes because they were identified
by PGD to carry single gene mutations for severe genetic disor-
ders (Saethre-Chotzen Syndrome for Lis04_Twist, Duchenne
Muscular Dystrophy for Lis12_DM, and Familial Adenomatous
Polyposis for Lis25_FAP); these PGD-derived hESC lines are
not intended to be used for therapy, but rather as models to
understand disease and hESC biology (Ben-Yosef et al., 2008;
Biancotti et al., 2010; Marteyn et al., 2011; Niclis et al., 2009;
Telias et al., 2013) and, to our knowledge, are unique in the avail-
ability of parental DNA, which allows comparisons between
the hESC and parental genomes. The second set of samples
includes genetically related dizygotic and monozygotic twin
blastomere-derived hESC lines (Chung et al., 2008; Ilic et al.,
2009) that enabled us to distinguish between changes that
occurred during gametogenesis, embryogenesis, and deriva-
tion. Identification of when aberrations occur will enable future
research using these models to determine optimal embryo cul-
ture, hESC derivation, and culture conditions that maximize their
genetic stability.
RESULTS
In order to dissect when during the process of embryogenesis
and hESC derivation genetic aberrations are arising, we
analyzed samples from two unique sets of samples (Figure 1).
First, we assessed the genetic stability of early-passage (pas-
sage 11–20) and high-passage (passage 44–60) samples from
three hESC lines, compared to DNA from parental blood sam-
ples (Figure 1). These three hESC lines were derived from
embryos carrying single-gene mutations identified by PGD and
are termed the ‘‘PGD-derived hESC lines.’’ Analysis of DNA
from the parental, early-passage hESC, and high-passage
hESC samples allowed us to definitively identify de novo duplica-
tions and deletions in the hESC lines, to determine whether they
occurred during the period between gametogenesis/preimplan-
tation embryo development and hESC derivation or during long-
term passage of the hESC lines, and to identify the parent of
origin of the duplicated and retained alleles, respectively. In addi-
tion, wewere able to distinguish between regions of homozygos-
ity that were the result of loss of one parental allele followed by
duplication of the remaining allele from the other parent and
those that were likely acquired through normal Mendelian inher-
itance of homozygous alleles in cases where both parents
shared the same allele. Second, we analyzed early-passage
(passage 11–16) samples from nine ‘‘twin blastomere hESC
lines,’’ which were derived using single blastomeres isolated
from four sibling embryos (Figure 1, inset). One embryo yielded
four lines, another embryo yielded three lines, and two embryosports 4, 1288–1302, September 26, 2013 ª2013 The Authors 1289
Figure 1. hESC Lines and Parental DNA Samples Used in This Study
Schematic diagram summarizing the samples collected for analysis relating to the PGD-derived hESC lines. (inset) Diagram showing relationships among the nine
twin blastomere (UCSF-B) hESC lines. Embryos 1, 2, 3, and 4 are dyzygotic twins; UCSF-B1, -B2, -B3, and -B4, as well as UCSF-B5, -B6, and -B7 are
monozygotic twin lines. See also Figures S4, S5, and Table S1.yielded one line each. Analysis of these monozygotic and dizy-
gotic twin lines enabled us to determine whether the copy num-
ber variations were likely to be inherited or arising de novo, and
to distinguish whether the de novo variations arose during the
period encompassing gametogenesis, preimplantation embryo
development, or hESC derivation and early passage.
All samples were analyzed by high-resolution SNP genotyping
using amicroarray platform interrogating over 1million SNPs (the
Illumina Omni1 BeadChip). Replicate error analysis was per-
formed to verify the relationships among the samples (Table
S1). A replicate error value of80% indicates that a pair of sam-1290 Cell Reports 4, 1288–1302, September 26, 2013 ª2013 The Auples are not related to each other, whereas a value of 85%–
90% indicates a parent-child or full-sibling relationship, and a
value of >99% indicates a self or identical/monozygotic twin
relationship. As expected, these results confirmed the father-
mother-child trios for the PGD-derived hESC lines (Table S1),
the full-sibling relationships among the four embryos and the
identical twin relationships among the hESCs lines derived
from different blastomeres of the same embryo (Table S1) for
the twin blastomere hESC lines. Copy number variations
(CNVs) were identified using CNV Partition 3.1.6 (Illumina),
visual inspection of the BAF and LogR Ratio plots, and/orthors
karyotyping (see Experimental Procedures; Extended Experi-
mental Procedures for further details).
Analysis of PGD-Derived hESC Lines
Early and high-passage samples were analyzed by karyotyping.
These results revealed no karyotypic abnormalities in the early
and high Lis04_Twist1 and Lis25_FAP samples and the early-
passage Lis12_DM1 sample. Only the high-passage Lis12_DM1
sample was shown to have a karyotypic abnormality, consisting
of a pericentric inversion on chromosome 7 and awhole chromo-
some duplication of chromosome 17 (Figure 2A).
The SNP genotyping analysis of the same samples was able to
detect the duplication of chromosome 17, but not the pericentric
inversion on chromosome 7, in the high-passage Lis12_DM1
sample (Figures 2B and S1; Table S2). The SNP genotyping anal-
ysis also identified deletions and regions of homozygosity that
cannot be detected by karyotyping (Figures 2B and S1; Table
S2). All of the novel deletions and regions of homozygosity
were present in both the early- and high-passage samples.
The BAF and LogR ratio plots for the two largest identified
genomic aberrations are shown in Figure 3 and confirm that
the region of homozygosity on chromosome 7 of the Lis04_Twist
line was present in both the early and high-passage samples
(Figure 3A), and the duplication of chromosome 17 in the
Lis12_DM1 line was present in the high-passage sample, but
not in the early-passage sample (Figure 3B).
We then wished to determine the parent of origin of the dupli-
cated chromosome 17 in the Lis12_DM1 high-passage sample.
Some SNPs on chromosome 17 were homozygous in both
parental genomes and discordant between parental genomes
for the Lis12_DM1 hESC line (i.e., AA in the maternal and BB
in the paternal genome, or BB in the maternal and AA in the
paternal genome). For these SNPs, we plotted the BAF values
for the maternal, paternal, and high-passage hESC samples,
rank ordered according to the BAF value in the hESC sample.
We reasoned that the BAF for the hESC sample should be
closer to the BAF of the parent of origin of the duplicated chro-
mosome. For example, if the maternal genotype is AA, the
paternal genotype is BB, and the paternal allele is duplicated,
then the hESC sample genotype should be ABB, making the
hESC BAF closer to the paternal BAF. In this way, we were
able to determine that the duplicated chromosome 17 in the
Lis12_DM1 high-passage sample was of paternal origin
(Figure 3C).
Regions of homozygosity can occur either from loss of hetero-
zygosity, in which one parental allele is lost and the other is
duplicated, or from normal Mendelian inheritance of a series of
alleles that are the same on the inherited maternal and paternal
chromosomes. In order to distinguish between these two alter-
natives, we further analyzed the SNP genotyping data and per-
formed short tandem repeat (STR) marker analysis for three
regions of homozygosity detected from the SNP genotyping
data. STRs, also known as microsatellites, consist of variable
numbers of repeats of 2–6 bp sequences, which are highly poly-
morphic. See Table S3 for details on the polymorphic markers
used. Our SNP genotyping results demonstrated that, for the
large region of homozygosity on chromosome 7 in the
Lis04_Twist hESC line (encompassing60 Mb), all of the homo-Cell Rezygous alleles in the hESC line were present in the paternal sam-
ple, but many were not found in the maternal sample. Our finding
suggests that this region of homozygosity arose from loss of the
maternal allele and duplication of the paternal allele. This
conclusion was confirmed by the polymorphic marker analysis,
which showed that not only was the Lis04_Twist line homozy-
gous for all tested markers, but that these markers could only
have been inherited from the paternal genome (Figure 4A; Table
S3). In contrast, our SNP genotyping results for the small regions
of homozygosity on chromosome 8 in the Lis12_DM and on
chromosome 12 in the Lis25_FAP lines (both approximately 1
Mb in extent) showed that the alleles present in the hESC lines
could have originated from either parent or both parents. For
these regions of homozygosity, the STR analysis showed that
the hESC lines were heterozygous for at least one marker, sup-
porting the conclusion that one set of homozygous alleles was
inherited from each parent (Figures 4B and 4C). High fre-
quencies of regions of homozygosity are more common in pop-
ulations that arose from small founder group, such as the Ashke-
nazi Jewish population from which these hESC lines were
derived. For the Lis12_DM line, the observed alleles at each
marker locus could have been inherited from either parent (Fig-
ure 4B), but, for the Lis25_FAP line, the parent of origin for the
three heterozygous marker loci could be definitively assigned
(Figure 4C).
Therefore, of the 13 identified regions of homozygosity, the
parent of origin could be identified from the SNP genotyping
data only for the largest one (60 Mb) located on chromosome 7
in the Lis04_Twist line. This validated region of LOH was present
in both the early and high-passage samples and likely arose
during preimplantation embryo development, derivation, or early
hESC culture. However, this was the only one out of the three
regions tested by STR analysis to be validated as an LOH event.
We conclude that the majority of small (1 Mb) regions of homo-
zygosity identified in early-passage hESC lines by SNP genotyp-
ing analysis result from normal biparental inheritance of highly
homozygous alleles.
Because we previously observed that CNV analysis from SNP
genotyping data can result in a high percentage of false-positive
calls (Laurent et al., 2011), we performed qPCR validation using
TaqMan assays specifically designed to measure copy number
on the three deletion calls identified in the PGD-derived hESC
lines and found that two out of three deletions were confirmed
(Lis12 chr3 single-copy deletion, Lis12 chr4 loss of both copies
were confirmed). The Lis25 chr3 single-copy deletion was not
confirmed and was thus concluded to be a false-positive
deletion call from SNP genotyping (Table 1; Figure S2). From
the SNP genotyping data, we were able to determine that the
retained alleles for the confirmed single-copy deletion on chro-
mosome 3 in the Lis12_DM line was of maternal origin
(Table S4).
A summary of the SNP genotyping, karyotype, STR marker
analysis, and CNV qPCR results is shown in Table 1. Overall,
we saw that the two validated deletions and the validated region
of LOHwere present in both the early and high-passage cultures,
suggesting that they arose during preimplantation embryo devel-
opment, derivation, or early passage of the hESC lines. None of
these aberrations were detectable by karyotyping. Weports 4, 1288–1302, September 26, 2013 ª2013 The Authors 1291
(legend on next page)
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Figure 3. Representative BAF and LogR Ratio Plots
(A and B) Data illustrating a region of homozygosity on chromosome 7 in the early and high-passage samples of the Lis04_Twist hESC line (A) and a duplication of
chromosome 17 in the high-passage sample of the Lis12_DM hESC line (B).
(C) B allele frequency data analysis showing the paternal origin of the duplicated chromosome 17 in the high-passage Lis12_DM1 culture.investigated whether these deletions included genes for which a
decrease in expression might result in a selective advantage in
culture, but neither the Lis12_DM deletion on chromosome
3 nor the Lis12_DM deletion on chromosome 4 encompassed
any identified genes.
The only identified genetic aberrations in the PGD-derived
hESC lines that arose during long-term passage (were absent
in the early-passage samples and present in the high-passage
samples) were the large pericentromeric inversion on chromo-
some 7 and the duplication of the entire chromosome 17, both
in the same line (Lis12_DM).Figure 2. Results for the PGD-Derived hESC Lines
(A) Karyotypes at early and high passage for the PGD-derived hESC lines. The in
passage sample of the Lis12_DM hESC line are highlighted in the red boxes.
(B) CNVs that were not present in the parental DNA samples identified by SNPGen
deletions in blue, and regions of homozygosity in green.
See also Figure S1 and Table S2.
Cell ReAnalysis of the Twin Blastomere hESC Lines
Analysis of the nine twin blastomere lines was focused on distin-
guishing between genetic aberrations that arose during early
preimplantation development and those that arose during deri-
vation and early culture of the hESC lines, and therefore these
lines were analyzed at early passage only. The twin blastomere
hESC lines were derived from four sibling embryos (embryo 1,
2, 3, and 4) from the same parents, with lines UCSF-B1, -B2,
-B3, and -B4 derived from embryo 1, UCSF-B5, -B6, and -B7
from embryo 2, UCSF-B8 from embryo 3, and UCSF-B9 from
embryo 4 (Figure 1, inset).version in chromosome 7 and the duplication of chromosome 17 in the high-
otyping analysis in the PGD-derived hESC lines. Duplications are shown in red,
ports 4, 1288–1302, September 26, 2013 ª2013 The Authors 1293
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Figure 4. SNP Genotyping and STR Marker
Analysis Data for Regions of Homozygosity
For the SNP genotyping analysis, the A alleles are
shown in purple, and the B alleles in pink. For the STR
analyses, the amplicon sizes (numbers of repeats) for
each repeat sequence are shown. Maternal alleles
are shown in red, paternal alleles are blue, and the
parental allele(s) of origin are indicated in bold type-
face.
(A) Lis04_Twist, chr7.
(B) Lis12_DM, chr8.
(C) Lis25_FAP, chr12.
See also Tables S3 and S4.
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Even though parental DNAs for the twin blastomere lines were
not available for analysis, the study ofmonozygotic (LinesUCSF-
B1, -B2, -B3, and -B4 and lines UCSF-B5, -B6, and -B7) and
dizygotic twin blastomere hESC lines enabled us to infer whether
observed variants were inherited or arose de novo. Furthermore,
the sets of monozygotic twin lines derived from the same embryo
enabled us to distinguish between changes that occurred during
gametogenesis/embryogenesis and those that occurred during
hESC derivation/early culture.
The copy number variations detected by SNP genotyping
analysis of the twin blastomere lines are shown in Figure 5A
(see also Table S5). If a given variant was present in all of the
monozygotic lines derived from the same embryo, it is shown
once. In cases in which there was a discrepancy among the
lines derived from the same embryo (e.g., for the chromosome
12 duplication present in UCSF-B7 and absent in UCSF-B5
and -B6), both the normal and duplicated variants are shown
and annotated. A total of 34 CNVs were present in lines from
more than one sibling embryo (Table S6; e.g., aqua boxes in
Figure 5A) and therefore were likely to be inherited. Twelve sub-
chromosomal variants were observed in all of the lines from one
embryo (i.e., all of the monozygotic twin lines from a given
embryo; Table S6; e.g., green boxes in Figure 5A). These vari-
ants, therefore, must have arisen prior to the 8-cell stage; they
could have been either inherited or created de novo during
gametogenesis or the first two cleavage cycles. To determine
whether these variants were most likely inherited or created de
novo, we examined the frequency with which each of these
variants was observed in the Database of Genomic Variants
(DGV). In Table S6, we determined that, if the variant was
present in only one embryo and was either new (not seen in
DGV) or had a frequency of %1% in DGV (a commonly used
definition for a ‘‘rare’’ allele), we then concluded that the variant
was de novo. We used population frequency information from
DGV because parental DNA was not available for the twin
blastomere lines, and we fully appreciate that our threshold is
arbitrary and the accuracy of our approach is limited by the small
numbers of data points for many copy number variations present
in DGV.
There was also a duplication of chromosome 12 in UCSF-B9,
which we judged to be a de novo aberration that arose during
in vitro passage of the hESC line, as an earlier passage of this
line had been karyotyped with a normal diploid result (data not
shown). Finally, we identified two events that were present in
only one line from a set of monozygotic lines (Table S6 and,
e.g., red boxes in Figure 5A). We therefore concluded that these
events were likely generated de novo during the derivation pro-
cess itself or during early culture. These two events were (1)
the duplication of chromosome 12 found inUCSF-B7, but absent
from its monozygotic triplet lines UCSF-B5 and -B6; and (2) the
aberration of chromosome 20 that was present in UCSF-B1 but
absent in its monozygotic quadruplet lines UCSF-B2, -B3, and
B4. Because the duplication of chromosome 12 was not present
in karyotype results from a separate culture of the UCSF-B7 line,
we concluded that this duplication arose during in vitro culture.
The BAF and LRR plots for chromosome 20 in the UCSF-B1
hESC line (Figure 5B) were consistent with an aberration
affecting the entire chromosome in some, but not all, cells inCell Rethe analyzed sample. In mosaic cases, such as this, it is difficult
to ascertain from the SNP genotyping data whether the aberra-
tion is a deletion or a duplication, because the distribution of
BAF values could be consistent with either type of abnormality,
and the change in the LRR is too small to allow confident discrim-
ination between the two possibilities. We noticed that the BAF
and LRR plots appeared slightly different for the q arm and the
p arm of chromosome 20, with the spread in the BAF being
slightly larger and the LRR being slightly lower for the p arm, sug-
gesting that there might be a deletion of the p arm and a duplica-
tion of the q arm (Figure 5B). We attempted to determine the
copy number for the q arm using qPCR, but the result was
indeterminate, likely due to the mosaicism in the sample. The
karyotype, which was performed on the same culture as the
SNP genotyping and collected one passage earlier, proved to
be the most informative assay for this aberration, revealing a
mosaic aberration of chromosome 20 in 13 out of 20 spreads
(data not shown). By G-banding, the aberration was determined
to be an isochromosome 20q [46XY,i(20)(q10)], which essentially
results in three copies of 20q and one copy of 20p, and is consis-
tent with the SNP genotyping findings.
Given the discordance for the chromosome 12 and chromo-
some 20 aberrations among monozygotic twin blastomere lines
derived from the same embryo, we can be certain that these var-
iants arose after fertilization. The BAF and LRR plots illustrate
that these findings were indeed seen in only one of the twin blas-
tomere lines from these two embryos (UCSF-B1 chr20 and
UCSF-B7 chr12, Figure 5B).
From the results of the analysis of all of the twin blastomere
hESC lines, we conclude that the majority of the detected vari-
ants were likely inherited, with a smaller number of variants
that were either inherited or acquired during gametogenesis or
the first few cell divisions, and only two aberrations that defini-
tively arose after fertilization.
A whole chromosome duplication of chromosome 12 was
identified in twin blastomere lines from two different embryos,
the UCSF-B7 line from embryo 2 and the UCSF-B9 line from
embryo 4. It is known that chromosome 12 duplications are quite
common in human pluripotent stem cell cultures and are thought
to confer a selective advantage in culture (Draper et al., 2004;
Laurent et al., 2011). To determine the parent of origin for these
duplicated chromosomes, we compared the BAFs of each of the
nonhomozygous loci in the UCSF-B7 and -B9 samples (defined
in this analysis by a BAF between 0.2 and 0.8 in both samples)
and found that the BAFs did not overlap. These results indicated
that the duplicated copies of chromosome 12 in the UCSF-B7
and UCSF-B9 were inherited from the mother for one line and
the father for the other line (Figure S3).
Having two embryos with duplications of the same chromo-
some allowed us to build the full haplotypes for chromosome
12 for the four sibling embryos, as well as most of the haplotypes
for the two parents, even though parental DNAs were not avail-
able for these lines (Figure 6; Table S7; see Experimental Proce-
dures and Extended Experimental Procedures for details). This
analysis revealed that the duplicated chr12s in the UCSF-B7
and UCSF-B9 lines were not from the same parent. Moreover,
the observed number and pattern of crossing-over events
make it likely that the duplicated chromosome 12 in UCSF-B7ports 4, 1288–1302, September 26, 2013 ª2013 The Authors 1295
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Cell Reis of maternal origin, whereas the duplicated chromosome in
UCSF-B9 is of paternal origin (Buard and de Massy, 2007; Lee
et al., 2011).
A subset of deletions in the twin blastomere hESC lines was
subjected to validation by qPCR (Figure S4). These experiments
validated a zero-copy deletion on chromosome 1 present in all
lines from embryo 1, and a one-copy deletion on chromosome
6 present in all lines from embryo 2. A one-copy deletion on
chromosome 3 in all lines from embryo 1 was not confirmed
by the qPCR and is therefore likely a false-positive call from
the SNP genotyping data. The CNV qPCR results were incon-
clusive for the aberration of chromosome 20 called in UCSF-
B1 from the SNP genotyping data, likely because only a
subpopulation of cells carried the isochromosome 20 detected
by karyotyping. These results, as well as a summary of the
SNP genotyping and probability calculation results, are listed
in Table S6.
DISCUSSION
This study presents results that directly answer questions per-
taining to the timing and parental origin of genetic aberrations
in hESCs. In order to answer fundamental questions about the
type and timing of mutational events occurring during the pro-
cess of embryogenesis, hESC derivation, and culture of hESC
lines, we studied two unique sets of hESC lines using a variety
of cytogenetic and molecular techniques, including karyotyping,
high-resolution SNP genotyping (with copy number variation
and haplotype analyses), STR analysis, and qPCR. The first
set consisted of three ‘‘trios,’’ each of which comprised one
PGD-derived hESC line and DNA from its two parents, which
enabled both definitive identification of de novo mutations, and
determination of the parent-of-origin of duplicated and deleted
alleles. The second set consisted of nine hESC lines derived
from single blastomeres isolated from four embryos from the
same parents. The fact that there were both monozygotic and
dizygotic ‘‘twin’’ hESC lines in this set allowed us to determine
the timing of mutational events in relation to key develop-
mental/biological steps.
Due to the inability to access to the parental DNA for most
established hESC lines, previous studies on the genetic
stability of hESCs have not been able to definitively identify
genetic aberrations that have been acquired before and during
early stages of hESC derivation. For hiPSCs, for which the
source differentiated cell cultures can be easily studied, it has
been demonstrated that most deletions and regions of homozy-
gosity were detected soon after reprogramming, whereas dupli-
cations tended to appear over time in culture (Laurent et al.,
2011; Mayshar et al., 2010). However, it is not appropriate to
generalize these findings in hiPSCs to hESCs, given the signifi-
cant differences in the processes of hiPSC reprogramming
and hESC derivation, which could be reasonably expected to
impose quite different mutagenic and selective pressures on
the cultures.
This study has enabled us to demonstrate that the two novel
deletions and the single region of LOH in the PGD-derived
hESC lines were identified in both the early and high-passage
samples, and the single detected duplication in these lines wasports 4, 1288–1302, September 26, 2013 ª2013 The Authors 1297
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Figure 5. CNVs Identified Using SNP Genotyping in the Twin Blastomere Lines
(A) Summary of CNVs called in the twin blastomere lines. If a given variant was present in all of the lines derived from the same embryo, they are displayed
together. In cases in which there was a discrepancy among the lines derived from the same embryo, all variants are shown. Duplications are shown in red,
deletions in blue, regions of homozygosity in green, and an indeterminate region (either duplication or deletion, present in a subpopulation of cells) in purple.
Examples of variants present in two ormore embryos are in aqua boxes, examples of variants present in all lines from only one embryo are in green boxes, and the
two aberrations that are found in only one of multiple lines from a given embryo are in the red boxes. Only chromosomes for which at least one variant was
detected are shown.
(B) Representative BAF and LogR Ratio plots illustrating the chromosome 20 aberration in one line from Embryo 1 and the chromosome 12 duplication in one line
from Embryo 2.
See also Tables S5 and S6.present in a high-passage sample only (Table 1). Taken together,
the previous reports on hiPSCs and results from the PGD-
derived hESC lines presented in this study suggest that deletions
and regions of LOH are generated at least in part from events that
are common to the derivation and early culture of both hiPSCs
and hESCs (e.g., the selective pressures of clonal or low-density
culture). Therefore, they cannot be attributed solely to manipula-
tions that are specific to either reprogramming (such as
overexpression of reprogramming transcription factors or viral
transduction) or hESC derivation (such as embryo culture).
All of the duplications and deletions and four of the regions of
homozygosity identified by the SNP analysis were subjected to
validation by STR analysis and/or qPCR CNV analysis. The avail-
ability of parental DNA for the PGD-derived lines allowed us to
use the SNP genotyping data to determine the parent-of-origin
of the chromosomes involved in one out of one duplication
events, one out of three deletion events called from the CNV
analysis, and one out of 13 regions of homozygosity. The other
two deletions called from the CNV analyses were a loss of1298 Cell Reports 4, 1288–1302, September 26, 2013 ª2013 The Auboth parental copies and a call that failed to validate by qPCR
analysis. In addition, we found that variants for which the parent
of origin could be determined from the SNP genotyping data
were confirmed by the validation studies, whereas variants for
which the parent of origin could not be inferred from the SNP
genotyping data failed to validate (Table 1). The validated dele-
tions and region of LOH were paternal in one case and maternal
in one case, suggesting that there is not a strong parent-of-origin
bias, although the number of observations is too small to draw
statistically significant conclusions. The results from the PGD-
derived hESC analysis determined that novel deletions and
regions of homozygosity arise in the period encompassing
preimplantation embryo development and early-passage hESC
culture.
We used the twin blastomere hESC data to classify variants as
inherited (present in two or more embryos as represented by
dizygotic twin lines), likely inherited (present in only one embryo
with frequency >1% in DGV), likely de novo (present in only one
embryo and frequency <1% in DGV), or de novo (discordantthors
BB
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
Parent A
(likely paternal)
Parent B
(likely maternal)
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
UCSF-B1
P
P
P
P
P
P
P
P
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
P
P
P
P
P
P
P
P
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
UCSF-B7
Pink
i
Pink
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
Pink
i
Pink
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
UCSF-B9
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
Pink
i
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
UCSF-B8
Figure 6. Summary of Inheritance of
Parental Haplotypes in the Four Embryos,
which Were the Source of the Twin Blasto-
mere hESC Lines
Data from one representative hESC line are shown
for each embryo. See also Table S7.among blastomeres from the same embryo as represented by
monozygotic twin lines).
The results from the twin blastomere hESC lines showed that
for the embryos from which more than one monozygotic twin
line was derived (embryos 1 and 2), all of the likely de novo de-
letions and regions of homozygosity were observed in all mono-
zygotic twin lines. Considering these results together, we
conclude that a significant subset of the novel deletions and re-
gions of homozygosity seen in hESCs originate during the first
two cleavage cycles of the preimplantation embryo. This
conclusion may appear to be a curious coincidence in the
context of published results indicating that deletions and re-
gions of homozygosity tend to arise also during reprogramming
and early culture of hiPSCs (Hussein et al., 2011; Laurent et al.,
2011). Of note, two other studies published at around the same
time did not show the same trend; however, one study used
gene expression rather than DNA analysis to detect CNVs (May-
shar et al., 2010), whereas the other observed that some vari-
ants appeared with time in culture and others disappeared, re-
sulting in no net gain or loss of observed variants with time in
culture (Amps et al., 2011). However, it should be remembered
that the preimplantation embryos used for generation of hESCs
are cultured in vitro and therefore may be subject to selective or
mutagenic pressures that are similar to those imposed by re-
programming. There is growing independent evidence that
more than half of human in vitro fertilization (IVF) embryos,
which are the sources of cells used for the derivation of hESC
lines, contain aneuploid cells, and mosaicism is a frequently
occurring phenomenon during this preimplantation period (Bar-
bash-Hazan et al., 2009; Mertzanidou et al., 2013a, 2013b; Van-
neste et al., 2009; Wells and Delhanty, 2000). These data can
explain some of the aberrations observed in the early-passage
hESCs.Cell Reports 4, 1288–1302, SepAlthough parental DNA could not be
obtained for the twin blastomere lines,
the fortuitous occurrence of chromosome
12 duplications in two twin blastomere
lines from two different embryos allowed
us to define the complete chromosome
12 haplotypes for the four UCSF-B em-
bryos, as well as the nearly complete hap-
lotypes for the parental chromosome 12
s, including sites of meiotic crossing
over. These results revealed that the
duplicated chromosome 12 s in the
UCSF-B7 and UCSF-B9 lines originated
from different parents, and that the fre-
quency and location of crossing-over
events for the two parents was markedly
different, consistent with a recent publi-cation (Lee et al., 2011), and allowing us to infer that parent A
was likely paternal and parent B was likely maternal.
This study demonstrates the complementarity of the different
molecular and bioinformatic techniques used. Although CNV
analysis of SNP genotyping data was able to detect many small
duplications and deletions, as well as regions of homozygosity,
which were not detected by karyotyping, a large chromosomal
rearrangement was detected by karyotyping, but not by SNP
genotyping. Haplotype analysis of the SNP genotyping data
was able to identify the parent-of-origin for several variants in
the PGD-derived lines, as well as to infer the parental contribu-
tions to the duplicated and nonduplicated copies of chromo-
some 12 in the twin blastomere lines. STR and qPCR analyses
served as orthogonal assays for validation of findings from the
SNP genotyping data.
The valuable sample sets used in this study allowed us to
define and trace the origins of mutational events that occur dur-
ing critical steps in the development and derivation of embryonic
stem cell lines, including gametogenesis, the first few cell
divisions, and the derivation process, and show that genetic
aberrations can occur at every step. Our results demonstrate
proof-of-concept for several data analysis strategies, aimed at
determining the timing and parent-of-origin of mutational events,
and indicate that even more might be learned from analysis of
more extensive pedigrees (for which parental DNAs are available
for sets of monozygotic twin and sibling hESC lines) using ultra-
deep whole-genome DNA sequencing, which, in a single anal-
ysis platform, would allow the identification of copy number
variations, indels, point mutations, and rearrangements.
Taken in the context of previously published reports, our cur-
rent findings suggest that deletions and regions of LOH
frequently occur during derivation and early culture of both
hESCs and hiPSCs, whereas duplications more commonly arisetember 26, 2013 ª2013 The Authors 1299
over long-term culture. Indeed, there were no de novo duplica-
tions observed at early passage in any of the PGD or twin blas-
tomere lines. Of the four large duplications observed in this
study, we have evidence that all occurred after derivation of
the hESC line. The fact that additional deletions and regions
of homozygosity were not observed to arise during long-term
culture in either the PGD lines in this study, or in the iPSC lines
in a previously published study (Laurent et al., 2011), suggests
that conditions specific to the derivation process itself promote
the occurrence and selection of these types of aberrations.
Because the culture conditions were held constant for all pas-
sages of the lines examined in both studies, we infer that it is
more likely that the derivation process was the source of the de-
letions and regions of homozygosity. Moreover, in prior studies
from our lab and others, some deletions and regions of homozy-
gosity detected in early-passage hiPSC cultureswere not seen in
later passages of the same hiPSC lines (Hussein et al., 2011;
Laurent et al., 2011), suggesting that these aberrations may be
subject to negative selection during long-term culture.
Overall, our results highlight the importance of close moni-
toring of genomic integrity and the development of improved
methods and reagents for derivation and culture of human
pluripotent stem cell cultures to minimize selection for geneti-
cally abnormal cells and ensure the safety of pluripotent stem
cell-derived cells for clinical use. The similarity in the temporal
pattern of aberrations in hESCs and hiPSCs suggests that
the identification of factors that protect against the occurrence
of deletions/regions of homozygosity during reprogramming
might be useful also in preserving genetic stability during preim-
plantation embryo culture and hESC derivation. This may be
important given that the scarcity of starting material for hESC
derivation prevents large-scale hESC derivation studies from
being performed.EXPERIMENTAL PROCEDURES
In Vitro Fertilization, Donors, and Ethics Approval
PGD-Derived hESC Lines
The use of spare IVF-derived embryos following PGD for the generation and
research of hESCs was approved by the National Ethics Committee and is in
accordance with the guidelines released by the Bioethics Advisory Committee
of the Israel Academy of Sciences and Humanities (Ruth Arnon et al., 2001).
Twin Blastomere hESC Lines
Embryos were produced by IVF for clinical purposes, and surplus frozen
embryos were obtained with full informed consent and used in compliance
with Advanced Cell Technology’s Ethics Advisory Board and Institutional
Review Board.
hESC Derivation Protocol
The PGD-derived hESC lines were derived from the ICM of blastocyst stage
embryos (days 6–8 postfertilization), and twin blastomere hESC lines were
derived from single blastomeres isolated from the 8-cell stage (day 3 postferti-
lization) (Figure 1).
PGD-Derived hESC Lines
Derivation of hESC lines from blastocysts following PGDwas carried out using
established protocols and as we previously described (Frumkin et al., 2010).
Twin Blastomere hESC Lines
hESC lines were successfully established from single blastomeres from four
different 8-cell stage embryos. hESC lines derived from single blastomeres
isolated from the same embryo are considered to be monozygotic twin
hESC lines. Embryo 1 produced four monozygotic twin lines (UCSF-B1, -2,1300 Cell Reports 4, 1288–1302, September 26, 2013 ª2013 The Au-3, and -4), embryo 2 produced three lines (UCSF-B5, -6, and -7), embryo 3
produced one line (UCSF-B8), and embryo 4 produced one line (UCSF-B9).
Because all four embryos were donated by the same couple, hESC lines
from different embryos are dizygotic twin lines.
TheUCSF-B lines were derived under a protocol approved by the University
of California’s Committee on Human Research, and embryos were obtained
through UCSF IVF Tissue Bank from donors undergoing IVF who gave
informed consent.
The lines were derived according to the method described by Chung et al.
(2008).
hESC Culture
hESCs were cultured on inactivated MEFs and in hESC medium. The medium
was changed on a daily basis, and the cells were propagated until they
reached the passage desired for the study. hESCs at early passage (passage
10–20) and high passage (30–40 passages later) were expanded to 100 mm
Petri dishes, physically separated from the feeder cells and subjected to
DNA extraction.
Phenotypic Characterization of hESC Lines
The hESC lines included in this study have been characterized for self-renewal
ability, expression of undifferentiated pluripotent stem cell-specific markers,
karyotype, and pluripotent potential by forming embryoid bodies in vitro or
by teratoma induction in vivo. Characterization for the Lis04_Twist and
Lis12_DM lines was reported in Frumkin et al. (2010); in addition, we include
in this report representative images of immunofluorescent staining of the
Lis12_DM line in Figure S4. Characterization for the Lis25_FAP line is shown
in Figure S5. Full characterization for the twin blastomere lines is being
reported in a separate manuscript (T. Zdravkovic, K.L. Nazor, N. Larocque,
M. Gormley, M. Donne, N. Hunkapillar, G. Giritharan, H.S. Bernstein, G. Wei,
M. Hebrok, X. Zeng, O. Genbacev, A. Mattis, M.T. McMaster, A. Krtolica,
D. Valbuena, C. Simon, L.C. Laurent, J.F. Loring, and S. Fisher, unpublished
data).
Parental DNA
The parental DNA isolated from blood samples of the maternal and paternal
donors of the blastocysts for the PGD-derived hESC lines were analyzed
and compared to the corresponding hESC lines (Figure 1).
DNA Extraction
DNA was extracted from parental blood and hESC samples using the DNeasy
Blood and Tissue Genomic DNA Purification Kit (QIAGEN), following the
manufacturer’s instructions.
SNP Genotyping and Copy Number Variation Analysis
SNP Genotyping was performed on the Omni1 BeadChip (Illumina), which in-
terrogates 1 million SNPs across the genome. Two micrograms of genomic
DNA was amplified and labeled according to the manufacturer’s instructions.
The labeled product were hybridized to the array and subsequently scanned
with an Iscan (Illumina). For the SNP genotyping, we performed data cleaning,
filtering, SNP calling, and replicate error analysis with GenomeStudio.
CNVPartition v 3.1.6 is the CNV-calling algorithm used for calling the aberra-
tions in the samples.
Validation of Copy Number Aberrations and Single Base-Pair
Mutations by qPCR
qPCR CNV assays were performed according to the manufacturer’s instruc-
tions (Life Technologies). Samples of theWA09 hESC line and the HDF51 fibro-
blast line were used as diploid controls.
Short Tandem Repeat Analysis
For each region of homozygosity identified by SNP genotyping analysis, four to
seven sets of STRmarkers were selected (Table S4). We used only informative
markers that were heterozygous in at least one of the parents. This enabled us
to determine the parental contribution. PCR conditions were as previously
shown for single-cell polymorphic marker analysis (Malcov et al., 2007).thors
Statistical Analysis of SNP Genotyping Data
Replicate error analysis was performed in GenomeStudio and refers to the
fraction of genotypes that are identical for each pair of samples tested.
The B allele frequencies and LogR ratios were calculated in GenomeStudio
using the standard cluster files provided by the manufacturer.
For the PGD-derived hESC lines, the SNP genotyping data were used to
determine the origin of the copy number alterations. In the case of duplications,
the extra allele was identified from the B allele frequency (BAF) data by (1)
filtering out homozygous SNPs by removing loci for which the BAF was <0.1
or >0.9 in the hESC line; (2) removing indeterminate SNPs with BAFs between
0.4 and 0.6; and (3) determining the duplicated allele to be A if the BAF was
<0.4 and B if the BAF was >0.6. In the case of deletions, the remaining alleles
weresimply thegenotype valuescalled inGenomeStudio. For theparental allele
assignments, we used the genotype values provided by GenomeStudio.
Haplotype analysis of the twin blastomere lines for chromosome 12was per-
formed on SNPs for which at least one sibling twin blastomere hESC line was
heterozygous (i.e., had a BAF between 0.1 and 0.9). The extra chromosome 12
alleles for the lines with duplications, UCSF-B7 and UCSF-B9, were deter-
mined in the same way the extra chromosome 17 alleles were identified in
the Lis12_DM line, except that the availability of several closely related lines
allowed us to determine the identities of the duplicated alleles even when
the BAFs in the duplicated hESC lines were close to 0.5. By iteratively
comparing the chr12 genotypes for UCSF-B1, -B7, -B8, and -B9, we were
able to infer the chromosome 12 haplotypes for each UCSF-B line, as well
as both of the parents (Figure 6 and Table S7).
ACCESSION NUMBERS
The GEO accession number for the SNP genotyping data reported in this
paper is GSE49452.
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